CD5 and lymphoma: In this retrospective study, we retrieved 195 CD5+ DLBCL cases from the Huaihai Lymphoma Working Group (HHLWG) and analyzed the clinicopathological characteristics of CD5+ DLBCL, aiming to develop and validate a novel prognostic nomogram for individual prognosis evaluation.